European Patent Bulletin 2012/36 - European Patent Office
09.02.2013 • Views
Share Embed Flag

European Patent Bulletin 2012/36 - European Patent Office

European Patent Bulletin 2012/36 - European Patent Office

European Patent Bulletin 2012/36 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

START NOW

(A61K) I.1(2)<br />

Ling, Yi-He, Briarwood, New York 11435, US<br />

(74) Woods, Geoffrey Corlett, J A Kemp 14 South<br />

Square Gray's Inn, London WC1R 5JJ, GB<br />

(62) 10195772.8 / 2 305 224<br />

06750246.8 / 1 871 353<br />

(51) A61K 31/135 (11) 2 494 966 A1<br />

A61K 9/70 A61K 9/107<br />

A61K 9/06 A61P 25/00<br />

A61P 25/16 A61P 25/24<br />

(25) Zh (26) En<br />

(21) 10826091.0 (22) 28.10.2010<br />

(84) AL AT BE BG CH CY CZ DE DK EE ES FI FR<br />

GB GR HR HU IE IS IT LI LT LU LV MC MK<br />

MT NL NO PL PT RO RS SE SI SK SM TR<br />

(86) CN 2010/078189 28.10.2010<br />

(87) WO 2011/050728 2011/18 05.05.2011<br />

(30) 29.10.2009 CN 200910191252<br />

(54) STABILE ZUSAMMENSETZUNG AUS RA-<br />

SAGILIN<br />

STABLE COMPOSITION OF RASAGILINE<br />

COMPOSITION STABLE DE RASAGILINE<br />

(71) Chongqing Pharmaceutical Research<br />

Institute Co., Ltd., No. 565, Tushan Road<br />

Nan'an District, Chongqing 400061, CN<br />

(72) LIN, Jialiang, Chongqing 400061, CN<br />

DENG, Jie, Chongqing 400061, CN<br />

CHEN, Hao, Chongqing 400061, CN<br />

ZHANG, Tao, Chongqing 400061, CN<br />

(74) Witte, Weller & Partner, Königstrasse 5,<br />

70173 Stuttgart, DE<br />

A61K 31/137 → (51) A61K 9/16<br />

(51) A61K 31/155 (11) 2 494 967 A1<br />

A61K 31/60 A61K 45/06<br />

A61K 31/4045<br />

(25) En (26) En<br />

(21) 12170283.1 (22) 16.01.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

(30) 16.01.2007 US 885212 P<br />

(54) Neuartige Zusammensetzung zur Behandlung<br />

des Stoffwechselsyndroms<br />

Novel composition for treating metabolic<br />

syndrome<br />

Nouvelle composition pour le traitement<br />

du syndrôme métabolique<br />

(71) IPINTL, LLC, 39-15 Main Street, L102,<br />

Flushing, NY 11354, US<br />

(72) Chen, Chien-Hung, Forest Hills, NY New<br />

York 11375, US<br />

(74) Coehn, Markus, Fish & Richardson P.C.<br />

Mies-van-der-Rohe-Strasse 8, 80807 München,<br />

DE<br />

(62) 08727718.2 / 2 118 279<br />

(51) A61K 31/17 (11) 2 494 968 A1<br />

A61K 33/38 A61K 45/06<br />

A61K <strong>36</strong>/28 A61K <strong>36</strong>/30<br />

A61K <strong>36</strong>/77 A61P 17/00<br />

A61K 9/00 A61K <strong>36</strong>/63<br />

(25) De (26) De<br />

(21) 12001410.5 (22) 01.03.<strong>2012</strong><br />

(84) AL AT BE BG CH CY CZ DE DK EE ES FI FR<br />

GB GR HR HU IE IS IT LI LT LU LV MC MK<br />

MT NL NO PL PT RO RS SE SI SK SM TR<br />

BA ME<br />

(30) 01.03.2011 DE 202011003<strong>36</strong>2 U<br />

(54) Zusammensetzung, insbesondere dermatologische<br />

Salbe mit Olea Europaea<br />

Fruchtöl und Silber<br />

Compound, in particular dermatological<br />

ointment with Olea Europaea Fruit Oil and<br />

Silver<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

Composition, notamment pommade<br />

dermatologique avec de l'huile des fruits<br />

d'Olea Europaea et de l'argent<br />

(71) Dr. Theiss Naturwaren GmbH, Michelinstr.<br />

10, 66424 Homburg, DE<br />

(72) Theiss, Peter Prof. Dr., 66484 Winterbach,<br />

DE<br />

(74) Zeitler - Volpert - Kandlbinder, Herrnstrasse<br />

44, 80539 München, DE<br />

(51) A61K 31/18 (11) 2 494 969 A1<br />

A61K 47/40 A61K 47/18<br />

A61K 47/26 A61P 35/00<br />

(25) En (26) En<br />

(21) 12151966.4 (22) 11.05.2006<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK YU<br />

(30) 13.05.2005 US 681215 P<br />

13.05.2005 US 681234 P<br />

(54) Pharmazeutische Formulierungen von<br />

HDAC-Hemmern<br />

Pharmaceutical formulations of HDAC<br />

inhibitors<br />

Formulations pharmaceutiques d'inhibiteurs<br />

de HDAC<br />

(71) TopoTarget UK Limited, 7200 The Quorum,<br />

Suite 14, Oxford Business Park North Oxford<br />

OX4 2JZ, GB<br />

(72) Bastin, Richard J., Waterford, IE<br />

Hughes, Nicholas J., Swindon, Wiltshire SN3<br />

5BZ, GB<br />

(74) Wytenburg, Wilhelmus Johannes, et al,<br />

Mewburn Ellis LLP 33 Gutter Lane, London<br />

EC2V 8AS, GB<br />

(62) 06727086.8 / 1 901 729<br />

A61K 31/203 → (51) A61K 41/00<br />

(51) A61K 31/205 (11) 2 494 970 A1<br />

A61P 27/06<br />

(25) En (26) En<br />

(21) 11157012.3 (22) 04.03.2011<br />

(84) AL AT BE BG CH CY CZ DE DK EE ES FI FR<br />

GB GR HR HU IE IS IT LI LT LU LV MC MK<br />

MT NL NO PL PT RO RS SE SI SK SM TR<br />

BA ME<br />

(54) Verwendung von 3-(2,2,2-Trimethylhydrazinium)-Ethylpropionat<br />

oder eines pharmazeutisch<br />

verträglichen Salzes zur Behandlung<br />

eines Glaukoms mit erhöhtem<br />

Druck<br />

Use of 3-(2,2,2-trimethylhydrazinium)ethylpropionate<br />

or a pharmaceutically<br />

acceptable salt for treating high tension<br />

glaucoma<br />

Utilisation de 3-(2,2,2-trimethylhydrazinium)-ethylpropionate<br />

ou sel acceptable<br />

pharmaceutiquement pour traiter le glaucome<br />

à haute tension<br />

(71) Grindeks, a joint stock company, 53,<br />

Krustpils street, 1057 Riga, LV<br />

(72) Cirule, Helena, LV-1057, Riga, LV<br />

Dambrova, Maija, LV-1002, Riga, LV<br />

Vilskersts, Reinis, LV-2125, Baldone, LV<br />

Svalbe, Baiba, LV-2150, Sigulda, LV<br />

Jonane-Osa, Indra, LV-1057, Riga, LV<br />

Stonans, Ilmars, LV-1057, Riga, LV<br />

A61K 31/282 → (51) G01N 33/68<br />

A61K 31/337 → (51) A61K 9/107<br />

A61K 31/35 → (51) C07D 309/02<br />

(51) A61K 31/352 (11) 2 494 971 A1<br />

C07D 493/08 A61P 35/00<br />

(25) Zh (26) En<br />

241<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>36</strong>/<strong>2012</strong>) 05.09.<strong>2012</strong><br />

(21) 10848761.2 (22) 09.11.2010<br />

(84) AL AT BE BG CH CY CZ DE DK EE ES FI FR<br />

GB GR HR HU IE IS IT LI LT LU LV MC MK<br />

MT NL NO PL PT RO RS SE SI SK SM TR<br />

(86) CN 2010/078555 09.11.2010<br />

(87) WO 2011/120303 2011/40 06.10.2011<br />

(30) 02.04.2010 CN 201010139385<br />

(54) GAMBOGINSÄUREDERIVATE, VERFAH-<br />

REN ZU IHRER HERSTELLUNG UND<br />

VERWENDUNGEN DAVON<br />

GAMBOGIC ACID DERIVATIVES,<br />

PREPARATIVE METHODS AND USES<br />

THEREOF<br />

DÉRIVÉS DE L'ACIDE GAMBOGIQUE,<br />

PROCÉDÉS DE PRÉPARATION ET UTILI-<br />

SATIONS DE CEUX-CI<br />

(71) China Pharmaceutical University, No.24<br />

Tongjiaxiang Gulou District, Nanjing, Jiangsu<br />

210009, CN<br />

(72) YOU, Qidong, Nanjing Jiangsu 210009, CN<br />

WANG, Xiaojian, Nanjing Jiangsu 210009,<br />

CN<br />

YANG, Qian, Nanjing Jiangsu 210009, CN<br />

LU, Na, Nanjing Jiangsu 210009, CN<br />

LIN, Changjun, Nanjing Jiangsu 210009, CN<br />

GUO, Qinglong, Nanjing Jiangsu 210009, CN<br />

(74) ABG <strong>Patent</strong>es, S.L., Avenida de Burgos, 16D<br />

Edificio Euromor, 280<strong>36</strong> Madrid, ES<br />

(51) A61K 31/357 (11) 2 494 972 A2<br />

(25) Es (26) En<br />

(21) 10826142.1 (22) 29.09.2010<br />

(84) AL AT BE BG CH CY CZ DE DK EE ES FI FR<br />

GB GR HR HU IE IS IT LI LT LU LV MC MK<br />

MT NL NO PL PT RO SE SI SK SM TR<br />

(86) ES 2010/070634 29.09.2010<br />

(87) WO 2011/051521 2011/18 05.05.2011<br />

(88) 11.08.2011<br />

(30) 28.10.2009 ES 200930924<br />

(54) VERWENDUNG VON GAMBIEROL ZUR<br />

BEHANDLUNG UND/ODER PROPHYLAXE<br />

VON DURCH TAU- UND BETA-AMYLOID-<br />

PROTEINE VERMITTELTEN NEURODEGE-<br />

NERATIVEN ERKRANKUNGEN<br />

USE OF GAMBIEROL FOR TREATING<br />

AND/OR PREVENTING NEURODEGEN-<br />

ERATIVE DISEASES RELATED TO TAU<br />

AND BETA-AMYLOID<br />

UTILISATION DU GAMBIÉROL POUR LE<br />

TRAITEMENT ET/OU LA PRÉVENTION DE<br />

MALADIES NEURODÉGÉNÉRATIVES<br />

ASSOCIÉES AU TAU ET À LA BÊTA-<br />

AMYLOÏDE<br />

(71) Universidade De Santiago De Compostela,<br />

Edificio CACTUS - CITT, Campus sur, 15782<br />

Santiago de Compostela, ES<br />

(72) BOTANA LOPEZ, Luis Miguel, E-15782 Santiago<br />

de Compostela (A Coruña), ES<br />

ALONSO LOPEZ, Eva, E-15782 Santiago de<br />

Compostela (A Coruña), ES<br />

VALE GONZALEZ, Carmen, E-15782 Santiago<br />

de Compostela (A Coruña), ES<br />

(74) Pons Ariño, Angel, Glorieta Ruben Dario 4,<br />

28010 Madrid, ES<br />

(51) A61K 31/375 (11) 2 494 973 A1<br />

A61K <strong>36</strong>/00 A61K <strong>36</strong>/28<br />

A61K 9/107 A61P 17/00<br />

(25) It (26) En<br />

(21) 121577<strong>36</strong>.5 (22) 01.03.<strong>2012</strong><br />

(84) AL AT BE BG CH CY CZ DE DK EE ES FI FR<br />

GB GR HR HU IE IS IT LI LT LU LV MC MK<br />

MT NL NO PL PT RO RS SE SI SK SM TR<br />

BA ME<br />

(30) 04.03.2011 IT MI20110339<br />

(54) Topische Zusammensetzungen zur Behandlung<br />

und Vorbeugung von Hauterkrankungen,<br />

insbesondere durch ionisierende<br />

Strahlung erzeugte Strahlungsdermatitis

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!